期刊文献+

降钙素原、N前端脑钠肽、乳酸对评估ICU脓毒症患者预后价值的研究 被引量:3

Prognostic value of procalcitonin,N-terminal precursor natriuretic peptide and lactic acid in sepsis patients of the Department of Critical Care Medicine
原文传递
导出
摘要 目的探讨ICU脓毒症患者血浆降钙素原(PCT)、N前端脑钠肽(NT-pro-BNP)、乳酸(LAC)变化的临床意义及对预后评估的价值.方法对2017年6月至2019年6月江苏大学附属金坛医院重症医学科(ICU)收治的脓毒症患者70例(观察组)和30例同期到院进行健康体检者(对照组)为研究对象进行前瞻性分析.脓毒症患者在初入ICU时抽取静脉血测定其PCT、NT-pro-BNP、LAC,对照组抽取空腹静脉血测定其PCT、NT-pro-BNP、LAC,比较上述两组指标的差异.观察组依据转归分为生存组、死亡组;比较不同转归患者PCT、NT-pro-BNP、LAC的差异.采用Spearman检验作生存死亡转归患者的PCT、NT-pro-BNP、LAC的相关性分析.应用ROC曲线评价PCT、NT-pro-BNP、LAC对脓毒症患者预后评估的价值.结果观察组患者的PCT、NT-pro-BNP、LAC分别为(23.00±27.60)ng/L、(7665.50±8084.83)ng/L、(4.59±3.47)mg/L,较对照组增高,P均<0.05.死亡组患者的PCT、NT-pro-BNP、LAC分别为(45.65±30.64)ng/L、(9950.21±7118.21)ng/L、(6.79±3.00)mg/L,高于生存组,P均<0.05.Spearman相关性分析显示PCT、NT-pro-BNP、LAC与患者的生存转归呈负相关,r分别为-0.597、-0.323、-0.505,P均<0.05.ROC曲线显示:PCT的Cutoff值12.25 ng/L,灵敏度为0.998,特异度为0.698.NT-pro-BNP的Cutoff值2372.50 ng/L,灵敏度为0.963,特异度为0.488.LAC的Cutoff值2.8 mg/L,灵敏度为0.999,特异度为0.628.结论脓毒症患者PCT、NT-pro-BNP、LAC明显增高,联合检测PCT、NT-pro-BNP、LAC具有判断ICU脓毒症患者预后的价值. Objective To investigate the clinical significance of procalcitonin(PCT),N-terminal precursor natriuretic peptide(NT-pro-BNP),lactic acid(Lac)in sepsis patients of ICU and the value of prognosis evaluation of them.Methods Total 70 cases of sepsis patients were collected in the Department of Critical Care Medicine of our hospital between April 2016 and April 2018(observation group);at the same time 30 cases of healthy physical examination were enrolled(control group).Venous blood was extracted from sepsis patients to detect PCT,NT-pro-BNP and LAC when they entered ICU,and fasting venous blood was extracted from the control group to detect PCT,NT-pro-BNP and LAC,and the differences between the two groups were compared.The observation group was divided into survival group and death group.The differences of PCT,NT-pro-BNP and LAC were compared between the two groups.Spearman test was used for correlation analysis of PCT,NT-pro-BNP and LAC in patients with survival and mortality.ROC curve was used to evaluate the value of PCT,NT-pro-BNP and LAC in the prognosis of sepsis patients.Results PCT,NT-pro-BNP and LAC in the observation group were(23.00±27.60)ng/L,(7665.50±8084.83)ng/L and(4.59±3.47)mg/L,respectively,higher than the control group(P<0.05).PCT,NT-pro-BNP and LAC were(45.65±30.64)ng/L,(9950.21±7118.21)ng/L and(6.79±3.00)mg/L respectively in the death group,higher than that in the survival group(P<0.05).Spearman correlation analysis showed that PCT,NT-pro-BNP and LAC were negatively correlated with the survival outcome of patients,with r being-0.597,-0.323 and-0.505,respectively(P<0.05).The ROC curve showed that the cutoff value of PCT was 12.25 ng/L,the sensitivity was 0.998,and the specificity was 0.698;the cutoff value of NT-pro-BNP was 2372.50 ng/L,the sensitivity was 0.963,and the specificity was 0.488;the cutoff value of LAC was 2.8 mg/L,the sensitivity was 0.999,and the specificity was 0.628.Conclusion PCT,NT-pro-BNP and LAC in sepsis patients are significantly increased,and combined detection of PCT,nt-pro-bnp and LAC have a certain value in prognostic evaluation of sepsis patients.
作者 王珍 李国民 管双仙 袁冬 Wang Zhen;Li Guomin;Guan Shuangxian;Yuan Dong(Department of Critical Care Medicine,Affiliated Jintan Hospital,Jiangsu University,Changzhou 213200,China)
出处 《中华卫生应急电子杂志》 2020年第5期284-287,共4页 Chinese Journal of Hygiene Rescue(Electronic Edition)
基金 2017年江苏大学附属金坛医院院级课题(YJKT2017002)。
关键词 脓毒症 降钙素原 N前端脑钠肽 乳酸 预后 Sepsis Procalcitonin N-terminal precursor natriuretic peptide Lactic acid Prognosis
  • 相关文献

参考文献11

二级参考文献228

  • 1章云涛,丁国娟,方强.重症脓毒症患者血清脂多糖结合蛋白及其受体变化的临床研究[J].中国危重病急救医学,2006,18(2):78-81. 被引量:16
  • 2姚咏明.免疫功能紊乱在脓毒症发病中的作用及意义[J].中国危重病急救医学,2007,19(3):138-141. 被引量:63
  • 3Zeitoun AA, Gad SS, Attia FM, et al. Evaluation of neutrophilic CD64, interleukin 10 and proealeitonin as diagnostic markers of early- and late-onset neonatal sepsis. Scand J Infect Dis, 2010,42 : 299-305.
  • 4Lannerg~d A,Larsson A,Friman G,et al. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediatr, 2008,97 : 1061-1065.
  • 5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation,infection, and sepsis:clinical utility and limitations. Crit Care Med, 2008,36:941-952.
  • 6Nakamura A, Wada H, Ikejiri M, et at. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock, 2009,31 : 586-591.
  • 7Martini A, Gottin L, Menestrina N, et al. Procalcitonin levels in surgical patients at risk of candidemia. J Infect, 2010,60 : 425-430.
  • 8Tang BM, Eslick GD, Craig JC,et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis. Lancet Infect Dis, 2007,7 : 210-217.
  • 9Bouchon A,Facchetti F,Weigand MA,et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature,2001,410: 1103-1107.
  • 10Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1 : its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med, 2004, 141 : 9 - 15.

共引文献1017

同被引文献25

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部